Natera - Attractive Treatment Numbers Drive Momentum!
Reading Time: 1 minute
Business Driver: Natera (NTRA) specializes in genetic testing for the detection of serious and life-threatening diseases, with strong positioning through products like Signatera, Prospera, and Panorama. The flagship products include Panorama, a non-invasive prenatal test (NIPT) for detecting genetic abnormalities such as Trisomy 21 or microdeletions in the fetus; Signatera, a personalized, tumor-informed test for detecting minimal residual disease (MRD) and monitoring treatment response in cancer patients; and Prospera, a cfDNA-based test that...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
